Gray/White Matter Contrast in Parkinson’s Disease

Gray/white matter contrast (GWC) decreases with aging and has been found to be a useful MRI biomarker in Alzheimer’s disease (AD), but its utility in Parkinson’s disease (PD) patients has not been investigated. The aims of the study were to test whether GWC is sensitive to aging changes in PD patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Uribe, Carme, Segura, Barbara, Baggio, Hugo C., Abos, Alexandra, Garcia-Diaz, Anna I., Campabadal, Anna, Marti, Maria J., Valldeoriola, Francesc, Compta, Yaroslau, Bargallo, Nuria, Junque, Carme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881246/
https://www.ncbi.nlm.nih.gov/pubmed/29636679
http://dx.doi.org/10.3389/fnagi.2018.00089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881246/
https://www.ncbi.nlm.nih.gov/pubmed/29636679
http://dx.doi.org/10.3389/fnagi.2018.00089

Ejemplares similares